Pharma Journalist 8932 posts 0 comments

Novartis announced that, at primary analysis, the Phase III ASCEMBL study met its primary endpoint of statistically significant superiority in major molecular response (MMR) rate at 24…
Read More...

MedGenome, a leading genomic diagnostics, research and data company based in Foster City, CA and Bangalore, India, announced that it has formed a strategic discovery collaboration…
Read More...

Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, entered into a…
Read More...

ACADIA Pharmaceuticals Inc. announced the acquisition of CerSci Therapeutics, a clinical-stage biotechnology company with worldwide rights to a portfolio of novel compounds for…
Read More...

EpiVax, Inc. a Rhode Island-based company and recognized leader in the field of computational vaccinology, today announced it has out-licensed its COVID-19 vaccine candidate,…
Read More...

HitGen Inc. announced that the company has achieved a milestone in their strategic collaboration with Almirall to develop a novel class of drugs. The licensed compounds were identified…
Read More...

AbbVie and Harvard University announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop novel…
Read More...

Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company announced that it has entered into a strategic collaboration with Vir Biotechnology, a clinical-stage immunology…
Read More...

Catalent, Inc. announced that Catalent Cell & Gene Therapy will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-19…
Read More...

5th PREDiCT: 3D Oncology & Tissue Models Summit – The community of industry leading preclinical 3D model developers will once again gather this September to accelerate benchtop to…
Read More...